MRI Protocol Recommendations & Scan Parameters (2025–2026)

HighYieldMRI · Clinical Reference

MRI Protocol Explorer

Current (2025–2026) protocol recommendations with representative parameters. Pick a category, set your scanner vendor to translate sequence names, open a body part, and tick sequences off as you scan.

Compiled July 2026 · Radiographers/technologists & radiologists · Source-linked
Representative values, not prescriptions. Parameters vary by vendor, field strength (1.5 T vs 3 T), coil, and local preference, and are increasingly compressed by parallel imaging, compressed sensing, and deep-learning reconstruction. Vendor names map the closest common equivalent and differ by software version. ACR figures are ceilings/minimums, not optimal technique. Defer to your institutional protocol and the linked primary sources. Educational reference, not clinical or safety advice.
Vendor terminology
Sequence names switch with the vendor buttons; ticks save in this browser (JavaScript). Generic names describe the pulse-sequence family.66,67,68
Guidelines verified July 2026Representative values — defer to your institutional protocol.Tip: press Ctrl / ⌘ + P for a clean printable PDF.Spotted an error? Tell us

Overview


Cross-cutting 2025–2026 developments that shape every protocol below.

High-Yield Pearls — cross-cutting
  • MR safety (ACR 2024): a “full stop” final safety check precedes every scan, routine or emergency; new MR risk-assessment appendix for implants; strict Zone III/IV discipline.
  • Contrast (ACR 2025): macrocyclic / Group II agents are the lowest-risk GBCAs; weight-based dosing; group-based renal screening rather than a blanket eGFR cut-off.
  • Contrast-sparing is the trend: biparametric prostate, abbreviated liver/breast, and non-contrast MRA increasingly replace routine gadolinium.
  • Acceleration & AI: deep-learning reconstruction with parallel imaging cuts scan time substantially — validate image quality locally before clinical adoption.
Cross-cutting updates
MR safety (ACR)
  • Full stop / final check before scanning, routine and emergency.2
  • Pocketless attire; tether external equipment in Zones III/IV.1
  • New MR Risk-Assessment Appendix for implants with unclear conditions; remote-scanning staffing.2,3
Contrast media (ACR 2025)
  • Group II macrocyclic agents — routine eGFR screening optional; eGFR<30/AKI highest-risk; cumulative “GBCA burden”.4
  • Breastfeeding need not be interrupted; screening now risk-factor-targeted (CIN → CA-AKI).4
Acceleration & AI reconstruction
  • Deep-learning recon (AIR Recon DL, Deep Resolve, SmartSpeed, AiCE, ACS) layered on parallel imaging + compressed sensing; up to ~85% gradient-time reduction.5
  • Watch for sequence-specific artifacts, oversmoothing/"hallucination", poor low-field generalisation — validate locally.5
Gadolinium trend
  • Gadopiclenol: high-relaxivity macrocyclic at half the standard dose; FDA use expanded to neonates/infants (2026).6
  • Every GBCA in routine US use is now Group II.4

Neuro & spine


Brain and spine. Where a pathology needs a distinct protocol it is listed in full — set your vendor above to translate sequence names.

High-Yield Pearls — neuro & spine
  • Routine brain = T1, T2, FLAIR, DWI, SWI (± post-Gd 3D T1). DWI is the non-negotiable sequence — stroke, abscess, CJD, cellularity.
  • Stroke: DWI + FLAIR + SWI/GRE + MRA in minutes. A DWI-positive / FLAIR-negative mismatch implies onset <4.5 h → thrombolysis candidate in wake-up/unknown-onset stroke (WAKE-UP).
  • MS (2024 McDonald): 3D FLAIR is the primary detection sequence; central vein sign and paramagnetic rim lesions (optimally 3T SWI) add specificity; gadolinium is increasingly optional.
  • Epilepsy (HARNESS-MRI): 1 mm-isotropic 3D T1 + 3D FLAIR plus a high-resolution coronal T2 ⊥ the hippocampal long axis.
  • Brain tumour (BTIP): parameter-matched pre/post 3D T1 is what enables reproducible RANO response assessment.
  • Spine: sagittal T1 + T2 ± STIR; add fat-sat post-Gd for infection/tumour/post-op; screen the whole spine for cord compression or drop metastases.
Brain
Routine brain0/6

First-line brain screen. Add post-contrast T1 for tumour, infection, or active MS.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
or 3D T1Ax500–7008–155 / 1220–240320×256Anatomy
Ax3500–500090–1105 / 1220384–512
Ax8000–900090–1202400–25005 / 1220256TI↑ at 3T
Ax3000–5000min4–5230128–160b0/1000; ADC
Ax2720–402–3220256–320minIP; blood/mineral
post-Gd if indicatedSag 3D1900–23002–4~9001 iso240256Volumetry

ACR-ASNR-SPR practice pattern.7

Acute stroke0/5

Speed-first; DWI+FLAIR+SWI+MRA in minutes. Add neck CE-MRA/TOF for carotid/vertebral. Extended wake-up windows (>4.5–9 h) are evolving, not yet uniform guideline.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
Ax3000–4000min4–5230128–160b0/1000; ADC — infarct core
Ax8000–9000100–12024005230256DWI+/FLAIR− mismatch → likely <4.5 h
or GREAx2720–403230256Haemorrhage, susceptibility vessel sign
intracranialAx 3D20–253–70.6–1200320Circle of Willis; large-vessel occlusion
optionalAx150030–455230128Penumbra (PWI)

AHA/ASA; ESO; DWI–FLAIR mismatch; extended windows.8,9,10,11

Multiple sclerosis0/5

2024 McDonald + 2024 MAGNIMS–CMSC–NAIMS. ≤3 mm/no gap; consistent repositioning for follow-up.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
Sag 3D5000–8000~390 eff1800–22001 iso250256Primary lesion detection
pre ± post-GdSag 3D20002–4~9001 iso250256Single dose, ~10 min delay
Ax4000903230320Posterior fossa
Ax3000min4230160Exclude mimics
Ax2720–402–3220320Central vein sign / rim lesions (optimally 3T)

McDonald 2024; MAGNIMS–CMSC–NAIMS.12,13,14

EpilepsyHARNESS0/4

ILAE HARNESS-MRI. Correct head tilt/rotation on the localiser before the coronal T2.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
Sag 3D20002–4~9001 iso256256Morphology / cortex
Sag 3D5000–8000~390 eff1800–22001 iso250256FCD / gliosis
high-resCor obl5000–900090–1102 / 0180–200512⟂ hippocampal long axis; ~0.4 mm
if lesionAx2720–402–3220320Add post-Gd T1 if tumour/vascular

ILAE HARNESS-MRI.15

Brain tumourBTIP0/6

Standardised BTIP; identical pre/post parameters enable RANO response assessment.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
preSag 3D2100min400–4501 iso256256Parameter-matched
Ax4000100≤4 / 0240384
Ax80001202400≤4 / 0240256Pre-contrast
Ax4000min4240160b0/1000; ADC (cellularity)
post-GdSag 3D2100min400–4501 iso256256Identical to pre
advanced, optionalAx150030–455240128Perfusion (rCBV) ± spectroscopy

Consensus BTIP.16,17

Dementia / neurodegeneration0/5

Reformat coronal-oblique T1 through hippocampi for MTA (Scheltens); optional volumetry.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
coronal-oblique reformatSag 3D20002–4~9001 iso240256MTA ⟂ hippocampus
Ax800012024005230256Vascular burden
Ax40001005230320
Ax2720–402–3220320Microbleeds / CAA
Ax3000min4230160Exclude CJD/acute

Radiology Assistant; ACR appropriateness.18

Pituitary / sella0/4

Thin-section sella; dynamic post-contrast for microadenoma. Representative standard technique.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
preSag & Cor400–60010–152–3 / 0160–180320–512Small FOV, thin
Cor3000902–3160–180384Chiasm, cysts
dynamic post-GdCorminmin2–3160–180256~6 phases — microadenoma
post-GdSag & Cor400–60010–152–3160–180320Delayed
IAM / CPA (hearing loss)0/4

Thin 3D heavy-T2 (CISS/FIESTA-C/DRIVE) + post-Gd T1 for CN VII/VIII. Representative standard technique.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
Ax 3D6–103–50.5–0.6 iso150–160320Membranous labyrinth, CN VII/VIII
preAx500123180320IAM fat
post-Gd fat-satAx & Cor500123180320Vestibular schwannoma
Ax4000903–4200320Posterior fossa
Pediatric
  • Feed-and-wrap for infants; fast HASTE/single-shot "quick-brain" for shunted hydrocephalus (no gadolinium, no sedation).20,21
  • <24 months myelination incomplete — FLAIR insensitive to FCD; retain early scans for comparison.15
  • Macrocyclic Gd, single dose, omit where not needed.22
Spine
Cervical (routine)0/4

Add fat-sat post-Gd T1 for infection/tumour/post-op.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
Sag500–70010–153 / 0.3240–280384Marrow, alignment
Sag3000–4000100–1203 / 0.3240–280384Cord, discs
Sag3000–400040150–1703240–280320Oedema / trauma
or Ax T2 FSEAx600–80015–203–4 / 1160–180256–320Foramina, cord

Representative routine protocol.19

Thoracic (routine)0/4
SequencePlaneTRTETISlice/gapFOVMatrix/resOther
Sag500–70010–153–4 / 0.5320–400384Wide coverage — count levels
Sag3000–4000100–1203–4320–400384Cord
Sag350040150–1703–4320–400320Oedema
Ax35001004180–200256Through ROI

Representative routine protocol.19

Lumbar (routine)0/5
SequencePlaneTRTETISlice/gapFOVMatrix/resOther
Sag500–70010–153–4 / 1280–320384Marrow, alignment
Sag3000–4000100–1203–4 / 1280–320384Discs, canal
optionalSag350040150–1703–4280–320320Oedema / infection
Ax3500–45001003–4 / 1180–200320Angled through discs
optionalAx600123–4180–200320Foraminal fat

Representative routine protocol.19

MS cord0/4

MAGNIMS cord protocol; slice ≤3 mm.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
Sag3500100–1203260–280384Cord lesions
or STIRSag3000303260–280384≥2 of 3 sagittal contrasts
Ax35001003160–180256Full cord coverage — confirmation
post-Gd if activeSag & Ax600123260320Active lesions

MAGNIMS–CMSC–NAIMS.14

Infection / discitis0/4

Fat-sat post-Gd essential for epidural/paraspinal collection.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
Sag500–700123–4280–320384Marrow, endplates
or T2 fat-satSag350040150–1703–4280–320320Discitis/osteomyelitis
Ax35001004180–200256Canal, paraspinal
post-Gd fat-satSag & Ax600123–4280320Abscess / epidural phlegmon

Representative protocol.19

Cord compression / whole-spine0/4

Acute cord compression or cauda equina — large-FOV whole-spine screen.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
Sag35001003–4400+ (2 stations)384Whole spine — compression / drop mets
Sag350040150–1703–4400+320Marrow lesions
Ax35001004180–200256Targeted level
± post-GdSag600123–4400+320Leptomeningeal / mets

Musculoskeletal


Each joint lists its routine protocol plus pathology-specific/arthrography protocols in full. ACR figures are accreditation ceilings, not optimal technique.

High-Yield Pearls — musculoskeletal
  • Fat-sat fluid-sensitive (PD/T2 or STIR) on ≥1 plane finds marrow & soft-tissue oedema; T1 maps marrow and anatomy. ACR figures are accreditation ceilings, not optimal technique.
  • MR arthrography: dilute gadolinium to ~2 mmol/L (~1:200) intra-articular; the ABER view is key for the anteroinferior labrum / HAGL in shoulder instability.
  • Positioning drives the diagnosis: oblique-coronal ∥ supraspinatus (cuff), oblique-axial along the femoral neck (cam/alpha angle), radial reformats for the acetabular labrum, short-axis ⊥ metatarsals for Morton neuroma.
  • Metal (MARS): high receiver bandwidth, short TE, FSE not GRE, and STIR not spectral fat-sat; add SEMAC / MAVRIC-SL 3D multispectral for severe hardware artifact.
  • Whole-body (MY-RADS): axial DWI (b 50 & ~900) + Dixon T1; overall study quality is usually limited by DWI quality.
Knee
Routine (internal derangement)0/5

Fat-sat on ≥1 plane. ACR max 4 mm / 0.6 mm².

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
Sag2500–350030–403–3.5 / 0.3140–160320–384Menisci; ~0.4 mm
fat-satSag3000–400040–603–3.5140–160320Cartilage, cruciates
fat-satCor3000403140–160320Collaterals, menisci
fat-satAx3000603–4140–160288Patellofemoral cartilage
or DixonCor500–700123–4140–160320Marrow (non-FS)

ESSR 2024; ACR MSK.26,33

Cartilage / quantitative0/3

Quantitative T2/T1rho used in research and early OA; not yet routine clinically.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
fat-sat 3DSag 3D1200300.5–0.7 iso150320Morphological cartilage; reformats
Sag1500multi-echo3140320Collagen/water; T1rho adjunct
fat-satSag/Cor3000403140–160320Routine base

AJR 2024.31

MR arthrography (post-op)0/2

Post-op meniscal re-tear / cartilage. Macrocyclic Group II GBCA.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
fat-satSag/Cor/Ax500–700min3140–160320Dilute Gd ~2 mmol/L intra-articular
fat-satone plane3000603140–160288Loose bodies, oedema

Gd dilution vs field.27

Shoulder
Routine (cuff / impingement)0/4

ACR max 4 mm / 0.8 mm².

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
Ax2500–3000303–4 / 0.3140–160320Labrum, biceps
fat-sat / STIRObl-Cor350050–603–4140–160320∥ supraspinatus — cuff
fat-satObl-Sag3000403–4140–160288Cuff muscles, Goutallier
Obl-Cor500–700123–4140–160320Marrow, fatty atrophy

ACR MSK.33

MR arthrography (instability)0/5

Instability work-up; ABER view essential.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
fat-satAx500–700min3140–160320Dilute Gd ~2 mmol/L; Bankart/SLAP
fat-satObl-Cor500–700min3140–160320Superior labrum
fat-satObl-Sag500–700min3140–160320
fat-sat, ABERABER obl-ax500–700min3140–160320Anteroinferior labrum, PASTA, HAGL
fat-satone plane3000603140–160288Cuff / oedema

Gd dilution; ABER.27

Hip
Routine / AVN0/4

AVN, marrow, referred pain.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
or T2 fat-satCor (pelvis)350040150–1704–5340–380320Both hips, marrow, AVN screen
Cor (pelvis)500–700124–5340–380384Marrow, AVN
Ax (small-FOV)2500303–4160–180320Symptomatic hip
fat-satCor (small-FOV)3000603–4160–180288Labrum, effusion
FAI / labral0/4

Radial reformats around the femoral neck are key.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
Obl-Ax2500302–3160320Along femoral neck — alpha angle (cam)
radialRadial2500303160320Acetabular clock-face labrum
fat-satCor/Ax3000603160–180288Chondrolabral
fat-sat, arthrography (optional)3 planes500–700min3160320Dilute Gd ~2 mmol/L distension

ACR MSK.33

Wrist
Routine0/4

Smallest FOV in MSK. ACR max 3 mm / 0.3 mm².

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
Cor-obl500–600min2–3 / 0.280–100256–320SL ligament, marrow; ~0.3 mm
fat-satCor-obl2500–3000402–380–100256–320TFCC, ligaments
fat-satAx250040380–100256Tendons, carpal tunnel
fat-satCor3000602–380–100256Oedema

ACR MSK.33

Arthrography (TFCC / instability)0/3

Three-compartment injection for intrinsic ligament / TFCC tears.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
fat-satCor500–600min280–100320Dilute Gd; TFCC / ligaments
fat-satAx500–600min2–380–100256
or 3D GRECor 3D1000min0.4 iso90320Intrinsic ligaments
Ankle & foot
Ankle (routine)0/4

Dixon efficient; oblique planes for ATFL. Ankle has no dedicated ACR table.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
Sag500–700123 / 0.3140–160320Marrow, tendons
fat-satAx3000403140–160288Tendons, ligaments (ATFL obl)
fat-satSag3000403140–160288Achilles, plantar fascia
fat-satCor3000603140–160288Osteochondral, ligaments
Forefoot (Morton / plantar plate)0/4

Planes prescribed relative to the metatarsals. ACR forefoot 3 mm / 0.4 mm².

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
fat-sat, short-axisShort-ax3000603 / 0.3100–120256⟂ metatarsals — Morton, plantar plate
short-axisShort-ax500123100–120256Neuroma (T1-iso), marrow
fat-sat, long-axisLong-ax3000403100–120256Plantar plate
fat-satSag3000603100–120256

ACR MSK.33

Techniques & whole-body
Fat suppression, 2D vs 3D & acceleration
  • Spectral fat-sat = best SNR but fails off-isocentre/near metal; STIR = most uniform; Dixon (increasingly default) gives water/fat/in/opposed in one acquisition.23
  • 2D FSE is the workhorse; 3D isotropic (SPACE/CUBE/VISTA/MVOX) gives sub-mm reformats — but ACR still requires each plane separately acquired.24,25
  • DL-accelerated / abbreviated joint protocols validated with preserved accuracy.28
Metal artifact reduction (MARS)0/3

Optimise first: high bandwidth, thin slices + large matrix, short TE, FSE/TSE + STIR (avoid GRE near metal).

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
Cor/Ax4000301503–4per joint320High BW 400–540 Hz/px; STIR not spectral FS
VAT / SEMACper joint600min3–4per joint320View-angle tilt; SEMAC-CS through-plane
SEMAC / MAVRIC-SLper joint4000803–4per joint2563D multispectral

Skeletal Radiology 2024; MAVRIC-SL 2025.29,30

Whole-body (MY-RADS / MET-RADS-P)0/3

Myeloma / metastatic prostate; overall quality is usually limited by DWI quality.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
multi-stationAxlongminSTIR5–6multi128b50–100 & 800–900; ADC
T1, multi-stationAxmindual-echo5–6multi256Water/fat/in/opposed
and T2 FSE/STIRSag600124whole spine384Whole spine

MY-RADS.32

Pediatric
  • Smaller FOV, child-sized coils, higher relative resolution; shorter protocols reduce sedation.34
  • JIA: fluid-sensitive FS/STIR + T1; fat-sat T1 post-Gd within ~5–10 min for enhancing synovitis; DWI emerging as a non-contrast biomarker.35,36
  • Normal physes / red marrow can mimic pathology — pair fluid-sensitive FS with a fat-sensitive (T1/Dixon) sequence.

Body & oncology


Structured systems (PI-RADS, LI-RADS, MY-RADS) specify acquisition and interpretation. Screening/surveillance uses biparametric or abbreviated, contrast-sparing protocols — listed separately in full.

High-Yield Pearls — body & oncology
  • Structured systems define both acquisition and interpretation: PI-RADS v2.1 (prostate), LI-RADS (liver), VI-RADS (bladder), O-RADS (ovary), ccLS (renal), MY-RADS (whole-body).
  • Prostate: mpMRI = T2 + DWI (high b ≥1400) + DCE (≤15 s temporal); biparametric screening (PRISM) drops contrast and the endorectal coil.
  • Liver: extracellular agent for the dynamic study; gadoxetate adds a ~20-min hepatobiliary phase; abbreviated non-contrast (T2 + DWI) for HCC surveillance.
  • Breast: image on days 7–14 of the cycle to lower background enhancement; Kuhl abbreviated (FAST, ~3 min) approaches full-protocol accuracy.
  • Rectal (ESGAR): high-resolution oblique T2 ⊥ the tumour; DWI is integral to restaging (residual tumour vs fibrosis); no routine DCE.
  • Chemical shift (in/opposed-phase): adrenal adenoma if signal-intensity index >16.5%; also detects microscopic fat in renal masses (ccLS).
  • Obstetric/fetal & PAS: 1.5 T, no contrast, no sedation; single-shot T2 is the workhorse; placenta accreta uses the 7 SAR–ESUR features.
Prostate
mpMRI (PI-RADS v2.1)0/4

3T preferred, 1.5T acceptable; endorectal coil optional.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
Ax obl3000–5000100–1203 / 0120–200320–384+ sag/cor; ~0.4–0.7 mm; zonal anatomy
Ax3000–5000min3–4200–22096–128b0-100, 800-1000 + high b≥1400 (acq/calc); ADC
DCEAx 3Dminmin3200–220192Temporal res ≤15 s; post-Gd
Ax500–700104–5300–360256Haemorrhage, nodes, bone

PI-RADS v2.1.37

Screening bpMRI (PRISM)New0/2

PRISM (JAMA Oncology, June 2026): no contrast, no endorectal coil; stage-gated 2-step read; ≤15 min.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
Ax + 1 ortho3000–5000100–1203 / 0120–200320≤15 min total
Ax3000–5000min3–4200–22096–128b0/800 + high ~b1500; ADC

PRISM; PI-QUAL v2.38,39,40

Liver
Full diagnostic (extracellular agent)0/4

Multiphasic dynamic; chemical-shift for steatosis/iron.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
in/opposed-phaseAx 3Dmindual-echo3–4360–420256Chemical shift
± fat-satAx/Cor1500–250080–1005–6360–420320Lesion characterisation
Axlongmin5–6360–420128b0/50, 400–500, 800; ADC
dynamic post-Gd fat-satAx 3Dminmin3360–420256Late arterial / PV / delayed

LI-RADS 2024.41,42

Gadoxetate (hepatobiliary)0/5

Add hepatobiliary phase ~20 min post-injection.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
in/opposed-phaseAx 3Dmindual-echo3–4360–420256Chemical shift
± fat-satAx1500–250080–1005–6360–420320
Axlongmin5–6360–420128b0/50, 400, 800; ADC
dynamic post-GdAx 3Dminmin3360–420256Arterial / PV / transitional
hepatobiliary phaseAx 3Dminmin3360–420256~20 min post-injection

LI-RADS; AMRI.41,43

Abbreviated (non-contrast surveillance)0/2

Non-contrast HCC surveillance ~10 min.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
± fat-satAx1500905–6380256Surveillance
Axlongmin5–6380128b0/500/800; ADC

AMRI.43

Breast
Full dynamic0/4

Days 7–14 of cycle (premenopausal) to minimise background parenchymal enhancement.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
pre, fat-satAx 3Dminmin≤1–1.5320–360384Bilateral high-res
dynamic post ×4–5, fat-satAx 3Dminmin≤1–1.5320–360384≤60–90 s/phase; subtraction + MIP; kinetics
Ax3000–4000903–4320–360384Cysts, oedema
Axlongmin4320–360128b0/800; SPAIR; adjunct

EUSOBI; DWI WG.44,46

Abbreviated (Kuhl FAST)0/3

~3 min; diagnostic accuracy ≈ full protocol.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
pre, fat-satAx 3Dminmin≤1.5320–360384
1st post, fat-satAx 3Dminmin≤1.5320–360384Single post; subtraction + MIP
optionalAx3000904320–360320± DWI

Kuhl FAST.45

Rectum
Primary staging0/4

No routine DCE; spasmolytic optional.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
Sag3000–40001003200–240320Planning
high-resObl-Ax3000–40001003 / 0160–200320–512⟂ tumour; mrT, mrCRM, EMVI; <1 mm
high-resObl-Cor30001003160–200320Low tumours / anal canal
Axlongmin3–4200–240128b0/800–1000; nodes

ESGAR/Radiology Assistant.47

Restaging (post-neoadjuvant)0/2

DWI integral to distinguishing residual tumour from fibrosis.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
high-resObl-Ax3000–40001003160–200320–512Fibrosis vs tumour
Axlongmin3–4200–240128High b — residual tumour

ESGAR Part II.47

Pancreas & biliary
MRCP (standard)0/4

Heavily T2W; static bile/pancreatic fluid bright.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
Cor obl 3Dresp-trig500–7001–1.5 iso300–360320MIP / reformats
Cor radial800–100040–60 slab300256Quick overview
Ax/Cor904–5320–380256Parenchyma, ducts
± post-GdAx 3Dminmin3360256If mass/inflammation

ABC of MRCP.48

Secretin-enhanced MRCP0/2

IV secretin stimulates exocrine flow — duct dynamics / compliance.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
serialCor slab800–100040–50 slab300256Serial ~10–15 min post-secretin
Cor obl 3Dresp-trig6001–1.5 iso320320Baseline anatomy

Secretin-MRCP.48

Small bowel
MR enterography (standard)0/5

~1–1.5 L oral contrast for distension + antiperistaltic agent.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
Cor + Ax904–5380–420256± fat-sat; distension
Cor + Axminmin4–5380–420256Wall, mesentery
Axlongmin5380–420128b0/800; inflammation
motilityCorminmin8–10400192~20 s/level
dynamic post-Gd fat-satAx 3Dminmin3380–420256Enteric-phase mural enhancement

SAR consensus.49

Abbreviated (non-contrast)0/3

≤5 sequences, <12 min room time, no IV contrast.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
Cor + Ax904–5380–420256± fat-sat
Corminmin4–5400256Wall
Axlongmin5400128b0/800

Abbreviated MRE.49

Adrenal
Adrenal mass (adenoma vs non-adenoma)0/4

Chemical-shift (in/opposed-phase) is the workhorse: intracellular-lipid signal drop-out on opposed-phase → lipid-rich adenoma (signal-intensity index >16.5%, or visual dropout vs spleen). Lipid-poor/indeterminate → dynamic post-Gd (or CT washout). DWI does not reliably separate adenoma from malignancy.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
chemical shiftAxminin ~4.4 / opp ~2.24–5320–400256Adenoma drop-out; SI index >16.5%
± fat-satAx/Cor1500–2500904–5320–400256Cyst, phaeo (light-bulb), necrosis
dynamic post-Gd, fat-satAx 3Dminmin3320–400224Lipid-poor / indeterminate; phaeo, ACC, mets
adjunctAxlongmin5320–400128b0/800; does not separate adenoma vs malignancy

ACR incidental adrenal white paper; chemical-shift MR.78,79

Kidney
Solid renal mass (ccLS)ccLS0/4

Clear-cell Likelihood Score (ccLS 1–5) for indeterminate small (cT1) solid renal masses. Three core features: T2 signal of the enhancing tissue, corticomedullary-phase enhancement, and microscopic fat (in/opposed-phase drop-out); DWI and macroscopic fat are adjuncts. Subtraction confirms true enhancement.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
Ax + Cor2000–4000903–4320–380320Predominant T2 signal of enhancing tissue
chemical shiftAxmindual-echo3–4320–380256Microscopic (intracellular) fat drop-out
Axlongmin4–5320–380128b0/800; adjunct feature; ADC
multiphase post-Gd, fat-satAx/Cor 3Dminmin3320–380224Corticomedullary (key) / nephrographic / excretory; subtraction

ccLS (Radiology, How We Do It).80

Bladder
Bladder cancer (VI-RADS)VI-RADS0/3

VI-RADS (1–5) predicts detrusor (muscularis propria) invasion. Moderate bladder distension; image before biopsy/TURBT or ≥2 weeks after. T2 (structural) + DWI + DCE combine into the score; DWI is the dominant sequence.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
high-res, small-FOVAx + Sag + Cor3000–50001003–4200–250320–384Muscularis propria integrity; VI-RADS structural
dominantAx (± Sag)longmin3–4200–250128b0/800–1000 + calc b1400–2000; stalk/interface
DCEAx (± Sag) 3Dminmin≤3220–260224~30 s temporal; early tumour vs muscle enhancement

VI-RADS (Panebianco, Eur Urol 2018).81

Anal fistula
Perianal fistula (St James)0/5

Small-FOV centred on the anal canal; plane axial- and coronal-oblique orthogonal/parallel to the canal. St James grade 1–5 (intersphincteric → trans-sphincteric → supralevator, ± abscess/secondary tracks) + active vs fibrotic (T2/STIR-bright + enhancement = active). No luminal contrast needed.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
high-res, small-FOVAx-obl + Cor-obl3000–4000903 / 0180–220320Tract, internal opening, sphincter relation (St James)
Ax-obl + Cor-obl3000–400090150–1803180–220320Active tract/abscess bright; secondary extensions
Ax-obl500–700103–4200–240256Anatomy, ischioanal fat planes
Axlongmin4200–240128b0/800; abscess restricts; adjunct to post-Gd
Ax-obl + Cor-oblminmin3180–220256Active (enhancing) vs fibrotic; abscess wall

MRI of perianal fistulas (RadioGraphics 2025).82

Gynecologic / pelvis
Endometrial cancer0/5

ESUR 2025, aligned to 2023 FIGO.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
Sag3000–40001003–4200–240320
small-FOV, short-axis uterusObl30001003–4200–240320Myometrial invasion
Ax obllongmin3–4220–260128b0/800–1000
DCESag 3Dminmin3240224Invasion depth (equilibrium)
Ax500105320256Nodes

ESUR endometrial.50

Cervical cancer0/4

T2 + DWI for staging/response/recurrence; DCE optional.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
Sag3000–40001003–4200–240320
small-FOV ⟂ cervixObl-Ax30001003–4180–220320Parametrial invasion
Ax obllongmin3–4220–260128b0/800–1000
DCE optionalSag 3Dminmin3240224Research / recurrence

ESUR cervical.51

Ovarian / adnexalO-RADS0/5

O-RADS MRI risk score from solid-tissue enhancement — DCE time-intensity curve (low / intermediate / high) vs the outer myometrium; a non-DCE pathway uses delayed post-contrast enhancement relative to myometrium.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
small-FOVSag + Ax + Cor3000–40001003–4200–240320Solid tissue, locules, fat/fibrous
Ax500–700104–5300–340256Fat vs blood (pair with FS)
fat-satAx500–700104–5300–340256Endometrioma/haemorrhage vs fat
Axlongmin4–5300–340128b0/800–1000; solid components
DCEAx 3Dminmin≤3240–30022415 s temporal, start 30 s pre-Gd, 4 min; TIC vs myometrium

O-RADS MRI (ACR).69

Endometriosis (deep pelvic)0/4

ESUR 2025: fasting + antiperistaltic agent, moderate bladder filling, ± bowel / vaginal-rectal opacification; compartment-based reporting; T1 fat-sat is key to confirm haemorrhagic foci.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
high-res, multiplanarSag + Ax + Cor3000–40001003–4200–250320–384DIE: uterosacrals, torus, pouch of Douglas, rectovaginal
Ax500–700104–5300–340256Baseline
fat-satAx (± Sag)500–700104–5300–340256Confirm blood products (T1-bright persists)
cover kidneysCor30001004–5350–400320Ureteric involvement / hydronephrosis

ESUR endometriosis 2025.70

Fibroids / adenomyosis0/5

ESUR leiomyoma: pre-uterine-artery-embolisation map — fibroid number/size/FIGO location + enhancement (viability); report coexisting adenomyosis (junctional zone >12 mm; affects UAE outcome).

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
Sag3000–40001004240–280320Fibroid map (FIGO), junctional zone
Ax3000–40001004240–280320Number, size, location
Ax500–700105300–340256Haemorrhagic/red degeneration
Axlongmin4–5300128b0/800; atypical/rapid-growth (sarcoma caution)
DCE / post-GdSag + Ax 3Dminmin3260–300224Viability — pre-UAE (non-enhancing = poor target); ovarian supply

ESUR leiomyoma.71

Placenta accreta spectrum0/3

Obstetric, usually 3rd trimester; NO gadolinium; moderate bladder filling. SAR–ESUR 7 MRI features: dark intraplacental T2 bands, placental bulge, myometrial thinning, bladder-wall interruption, focal exophytic mass, abnormal vascularity, heterogeneity.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
T2, heavily-weightedSag + Ax + Cor904300–400256No contrast; dark T2 bands, bulge, myometrial thinning
Sag + Axminmin4300–400256Uterine/bladder interface, serosa
optionalAxlongmin5350–400128Optional — placental boundary delineation

SAR–ESUR PAS consensus.72

Bowel / acute abdomen
Appendicitis (non-contrast)0/5

US-first; MRI when ultrasound is inconclusive — the imaging of choice in pregnancy and often in children (no ionising radiation). 1.5 T preferred (limits fetal heating); no oral/IV contrast. Positive: dilated (>7 mm) blind-ending tubular structure, wall oedema, periappendiceal fluid/fat stranding, restricted diffusion.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
Ax + Cor904–5300–360256Large-FOV survey; blind-ending tube
fat-sat / STIRAx + Cor90150–1804–5300–360256Periappendiceal fluid, fat stranding
in/opposed-phaseAxmindual-echo3–4320–380256Appendicolith, blood, fat planes (no Gd)
Axlongmin4–5300–360128b0/800; inflamed wall, abscess
optionalCorminmin4–5320–380256Motion-robust; free fluid, bowel

ACR AC Right Lower Quadrant Pain 2022; MR appendicitis in pregnancy.73,74

Acute abdomen in pregnancy0/6

Non-contrast maternal survey for non-obstetric acute abdomen/pelvis — appendicitis, cholecystitis/choledocholithiasis, adnexal torsion, ovarian-vein thrombosis, urolithiasis/hydronephrosis, bowel obstruction. 1.5 T; multiplanar; add thick-slab MRCP if biliary.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
Ax + Cor + Sag904–5350–400256Diaphragm→pubis survey; fluid/oedema
fat-sat / STIRAx + Cor90150–1804–5350–400256Inflammation, oedema
in/opposed-phaseAxmindual-echo3–4350–400256Blood, fat, adrenal; no Gd
Axlongmin5350–400128b0/800; abscess, torsion, bowel
Cor + Axminmin4–5380–420256Bowel, ovarian vein, free fluid
if biliaryCor radial800–100040–60 slab300256Choledocholithiasis / CBD

MR acute abdomen in pregnancy (RadioGraphics).74

Obstetric / fetal
Fetal MRI (brain ± body)0/5

Complementary to neurosonography; 1.5 T standard (3 T acceptable — ACR–SPR: minimal fetal risk); NO contrast, NO maternal sedation. Single-shot T2 is the workhorse, re-planned to fetal anatomy for every stack; keep SAR in normal operating mode and minimise scan time.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
workhorse3 planes to fetal brain90–1403–4 / 0small (fetal head)256Re-plan each stack; cortex, ventricles, posterior fossa
3 planes to fetal body903–4fetal trunk256Thorax/abdomen, lung signal, GI
Multiplanarminmin3–4fetal256Heart/vessels, spine; motion-robust
Axminmin4–5fetal192Fat, meconium (bowel), haemorrhage, thyroid/liver
Axlongmin4–5fetal128b0/600–700; brain injury (ADC), blood/mineral (EPI/T2*)

ACR–SPR fetal MRI parameter; ISUOG fetal MRI 2023.75,76

Pediatric
  • Free-breathing with respiratory navigators/triggering; motion-robust radial acquisitions; feed-and-wrap for infants.52
  • DL / compressed-sensing acceleration; DL low-dose gadolinium reconstruction to cut contrast burden.
  • Paediatric IBD MRE: non-contrast / abbreviated protocols + DWI to avoid repeated gadolinium.
Pregnancy
  • MRI is preferred over CT for non-obstetric acute abdomen/pelvis and may be performed in any trimester when clinically indicated — no proven harm at 1.5 T or 3 T.3
  • Avoid gadolinium unless essential: GBCAs cross the placenta and have been associated with rare adverse fetal/childhood outcomes (stillbirth/neonatal death, inflammatory/infiltrative skin conditions).77
  • No routine sedation or fasting (unless MRCP); left-lateral decubitus in the 3rd trimester to relieve IVC compression; keep SAR in normal operating mode and minimise acoustic noise and scan time.

Cardiac & vascular


Modular, indication-based (SCMR). Heart protocols are assembled per clinical question; mapping and iron thresholds need local reference ranges.

High-Yield Pearls — cardiac & vascular
  • Modular SCMR protocols are assembled per clinical question; cine bSSFP is the functional backbone for volumes and wall motion.
  • Ischaemia: vasodilator (adenosine) stress-first perfusion, then rest; LGE for viability/scar (TI ~300–420 ms, 10–20 min post-Gd; PSIR is less TI-sensitive).
  • Tissue characterisation: native/post T1 & T2 mapping with ECV — always interpret against local reference ranges.
  • Myocarditis (2018 Lake Louise): one T2-based plus one T1-based criterion.
  • Iron (T2*): mid-septal short-axis ROI; >20 ms normal, <10 ms severe (10–20 ms mild–moderate).
  • MRA: first-pass CE-MRA with bolus timing; QISS or ferumoxytol for non-contrast MRA when GBCA is contraindicated.
Heart
Function / ischaemia0/3

Stress first, then ≥10 min before rest; add LGE for viability.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
SA stack + 2/3/4-ch~3~1.46–8 / 2340–380~1.8 mmFunction/volumes; ~35–50 ms/phase
vasodilator stress3 × SA~2~1sat-recovery8–10340128Adenosine; ~0.05–0.075 mmol/kg first-pass
SA + LAXR-R~3300–4206–834019210–20 min post-Gd; PSIR less TI-sensitive

SCMR protocols; cine/LGE params; 2025 perfusion consensus.53,54,58

Cardiomyopathy0/4

Native T1 ~950–1050 ms (1.5T) / ~1150–1200 ms (3T) — use local normals.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
SA + LAX~3~1.46–8340–380~1.8 mmFunction, wall thickness
native + postSA basal/mid/apicalMOLLI~1scheme8340160ECV with haematocrit
SAmulti8340160Oedema
SA + LAXR-R~3300–4206–8340192Mid-wall/patchy = non-ischaemic

SCMR/EACVI mapping.55,56

Myocarditis0/4

Updated (2018) Lake Louise: one T2-based + one T1-based criterion.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
SA + LAX~3~1.46–8340~1.8 mmFunction, pericardium
SAmulti8340160Oedema (T2 criterion)
native + post / ECVSAMOLLI~1scheme8340160T1 criterion
SA + LAXR-R~3300–4206–8340192Non-ischaemic pattern

Lake Louise 2018.57

Iron overload (T2*)0/3

Cardiac T2* is the gold standard for myocardial iron.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
septal ROIMid-SAmulti (2–18 ms)8–10340160R2*=1000/T2*; >20 ms normal, <10 severe
SA + LAX~3~1.46–8340~1.8 mmFunction
liverAx (liver)multi10380160LIC calibration (method-dependent)

T2* thresholds.63

Vessels (MRA)
CE-MRA0/3

General-purpose default; carotid, aorta, peripheral runoff.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
Cor 3Dminmin1–1.5per station~1 mmFirst-pass Gd; test bolus / bolus tracking
time-resolvedCor 3Dminmin1.5–2per station~1.5 mmDynamic (TWIST/TRICKS/4D-TRAK)
optional supplementAx 3D20–253–70.6–1200320Carotid / intracranial

CE-MRA vs TOF.60,61

Non-contrast MRA0/3

When gadolinium is contraindicated. Ferumoxytol steady-state (off-label) for infants/small vessels.

SequencePlaneTRTETISlice/gapFOVMatrix/resOther
Ax/Cor ECG-gatedR-Rminquiescent2–3per station~1 mmPeripheral runoff; renal-safe
Ax 3D20–253–70.6–1200320Carotid / intracranial
navigator, TSLIPCorminmininversion1.5–2300~1.3 mmRenal / aorta

QISS; non-contrast; ferumoxytol.60,61,62

Pediatric
  • Free-breathing, navigator & DL-accelerated cine replace multiple breath-holds; validated in children (2025–2026).64
  • Ferumoxytol for CE-MRA / 4D flow in infants and small-caliber low-flow vessels, outperforming gadolinium under anesthesia.65
  • 4D flow suits complex CHD anatomy; use pediatric resolution (2–2.5 mm³).59

References

Primary and authoritative sources, grouped by category. Vendor-nomenclature sources at the end.

Cross-cutting

  1. ACR — Advancing MR Safety With New Guidelines and Best Practices. acr.org
  2. ACR calls for input on new MRI safety guidelines. AuntMinnie. auntminnie.com
  3. ACR Manual on MR Safety: 2024 Update and Revisions. Radiology. doi:10.1148/radiol.241405
  4. ACR Manual on Contrast Media 2025 — guidelines explained. summary · ACR official
  5. Deep Learning–Based Acceleration in MRI. AJNR (2025/2026). ajnr.A8943
  6. FDA expands gadopiclenol (Vueway) to neonates and infants. ITN. itnonline.com

Neuro & spine

  1. Imaging of the Brain — clinical guideline (2024). Carelon. guidelines.carelon…
  2. AHA/ASA 2019 Early Management of Acute Ischemic Stroke. doi:10.1161/STR.0000000000000211
  3. ESO Guidelines on IV Thrombolysis for Acute Ischaemic Stroke. PMC7995316
  4. DWI–FLAIR mismatch in wake-up stroke (review). PMC8881675
  5. Thrombolysis in wake-up stroke based on MRI mismatch (2024). J Neurol Sci. jns-journal.com
  6. 2024 McDonald Diagnostic Criteria. National MS Society. nationalmssociety.org
  7. The 2024 Update to the McDonald Criteria: A Guide for Radiologists. AJR. doi:10.2214/AJR.25.33997
  8. 2024 MAGNIMS–CMSC–NAIMS consensus on MRI for MS diagnosis. Lancet Neurology. thelancet.com
  9. ILAE HARNESS-MRI recommendations (2019). ilae.org
  10. Consensus Brain Tumor Imaging Protocol for gliomas. PMC7283031
  11. Standardized brain tumor imaging protocols (2023). Front Radiol. frontiersin.org
  12. Dementia — Role of MRI. Radiology Assistant. radiologyassistant.nl
  13. Spine MRI planning & protocols. mrimaster. mrimaster.com
  14. MRI with “feed and wrap” and optimized anesthesia (2024). Front Pediatr. frontiersin.org
  15. Ultrafast brain MRI beyond shunted hydrocephalus. AJNR. ajnr.org
  16. Safety of GBCAs in Children — systematic review (2024). Radiology. doi:10.1148/radiol.241224

Musculoskeletal

  1. Fat-Suppression Techniques for 3-T MSK MRI. RadioGraphics. rg.341135130
  2. 3D isotropic vs conventional 2D sequences at 3 T (2025). PMC12296944
  3. ACR MRI Exam-Specific Parameters: MSK Module (rev. 3-5-2025). accreditationsupport.acr.org
  4. ESR Essentials: MRI of the knee — ESSR (2024). doi:10.1007/s00330-024-10706-7
  5. Shoulder MR arthrography: optimal gadolinium dilution vs field strength. JMRI. doi:10.1002/jmri.20788
  6. Deep-learning abbreviated shoulder MRI (2025). PMC12031227
  7. Managing hardware-related metal artifacts in MRI. Skeletal Radiology (2024). doi:10.1007/s00256-024-04624-4
  8. MAVRIC-SL vs STIR in lumbar instrumentation (2025). PMC12611744
  9. Quantitative Cartilage T2 and T1rho Mapping. AJR (2024). doi:10.2214/AJR.24.31655
  10. MY-RADS: WB-MRI in Myeloma. Radiology (2019). radiol.2019181949
  11. ACR MSK Module parameter table (rev. 3-5-2025). accreditationsupport.acr.org
  12. Imaging in juvenile idiopathic arthritis (2023). Pediatr Radiol. doi:10.1007/s00247-023-05815-2
  13. MRI of the knee in juvenile idiopathic arthritis. PMC7792535
  14. DWI for synovial inflammation in JIA. PMC5635098

Body & oncology

  1. Prostate cancer — PI-RADS v2.1. Radiology Assistant. radiologyassistant.nl
  2. PRISM: Prostate Imaging Standards for Screening MRI. JAMA Oncology (June 2026). PubMed 42275039
  3. New MRI standards for prostate cancer screening. AuntMinnie. auntminnie.com
  4. PI-QUAL v2 — prostate MRI quality (2024). Eur Radiol. doi:10.1007/s00330-024-10795-4
  5. CT/MRI LI-RADS 2024 Update: Treatment Response. Radiology. radiol.232408
  6. ACR LI-RADS. acr.org
  7. Abbreviated MRI for HCC Surveillance. RadioGraphics. rg.2020200104
  8. EUSOBI / ESR Essentials — breast screening (2024). Eur Radiol. doi:10.1007/s00330-024-10740-5
  9. Abbreviated breast MRI (Kuhl FAST). PubMed 24958821
  10. EUSOBI Breast DWI Working Group consensus. Eur Radiol. doi:10.1007/s00330-019-06510-3
  11. Rectal Cancer MR Staging / restaging. Radiology Assistant. radiologyassistant.nl
  12. ABC of MRCP. Insights into Imaging. PMC3292642
  13. SAR Consensus: Small-Bowel Crohn Strictures at CT/MRE. Radiology. radiol.243123
  14. Updated ESUR endometrial cancer guidelines (2025). Eur Radiol. doi:10.1007/s00330-025-11700-3
  15. ESUR cervical cancer MRI guidelines. PubMed 33852049
  16. WB-MRI surveillance for pediatric cancer predisposition (2024). Clin Cancer Res. aacrjournals.org

Cardiac & vascular

  1. SCMR Standardized CMR Protocols: 2020 update. PMC7038611
  2. Cine SSFP / LGE / TI parameters. MRIquestions. mriquestions.com
  3. SCMR/EACVI CMR Mapping recommendations. journalofcmr.com
  4. Native T1/T2 at 1.5 T vs 3 T. doi:10.1007/s00508-018-1411-3
  5. Modified (2018) Lake Louise Criteria — meta-analysis. PMC12131415
  6. SCMR Quantitative Myocardial Perfusion CMR (2025). journalofcmr.com
  7. 4D Flow CMR Consensus: 2023 update. PMC10357639
  8. QISS MRA — review. PMC6315503
  9. CE-MRA vs 2D TOF for carotid stenosis. AJNR. ajnr.org
  10. Vascular imaging with ferumoxytol. PMC5130335
  11. Cardiac & liver T2* thresholds. PMC8007896
  12. DL-accelerated cine in children (2026). Pediatr Radiol. doi:10.1007/s00247-026-06676-1
  13. Ferumoxytol MRA & 4D flow in pediatric CHD. PMC9777095

Vendor nomenclature

  1. MRI Acronyms — Cross-Vendor Comparison (Siemens Healthineers). PDF
  2. MRI Cross-Vendor Terminology (MRI acronyms). mrimaster. mrimaster.com
  3. Post-contrast 3D T1 TSE (SPACE/CUBE/VISTA/isoFSE/3D MVOX). PubMed. PMID 32017974

Gynecologic (additional)

  1. O-RADS MRI Risk Stratification System (ACR O-RADS MRI Committee). Radiology (2021). radiol.204371
  2. ESUR consensus: MRI for endometriosis — protocol, lexicon, compartment-based (2025). Eur Radiol. doi:10.1007/s00330-025-11611-3
  3. ESUR Guidelines: MR Imaging of Leiomyomas (2018). Eur Radiol. doi:10.1007/s00330-017-5157-5
  4. SAR–ESUR joint consensus: MRI of placenta accreta spectrum (2020). Eur Radiol. doi:10.1007/s00330-019-06617-7

Obstetric & acute abdomen (additional)

  1. ACR Appropriateness Criteria® Right Lower Quadrant Pain: 2022 Update. J Am Coll Radiol. JACR 2022
  2. MR Imaging Evaluation of Abdominal Pain during Pregnancy: Appendicitis & Other Nonobstetric Causes. RadioGraphics. rg.322115057
  3. ACR–SPR Practice Parameter for the Safe and Optimal Performance of Fetal MRI (2020). acr.org PDF
  4. ISUOG Practice Guidelines (updated): performance of fetal MRI (2023). Ultrasound Obstet Gynecol. doi:10.1002/uog.26129
  5. Ray JG et al. Association Between MRI Exposure During Pregnancy and Fetal/Childhood Outcomes. JAMA (2016). doi:10.1001/jama.2016.12126

Genitourinary & pelvic (additional)

  1. Mayo-Smith WW, et al. Management of Incidental Adrenal Masses: A White Paper of the ACR Incidental Findings Committee. J Am Coll Radiol (2017). JACR
  2. Chemical Shift MR Imaging of the Adrenal Gland: Principles, Pitfalls, and Applications. RadioGraphics (2016). rg.2016150139
  3. Managing the Indeterminate Renal Mass with the MRI Clear Cell Likelihood Score (How We Do It). Radiology (2021). radiol.210034
  4. Panebianco V, et al. Multiparametric MRI for Bladder Cancer: Development of VI-RADS. Eur Urol (2018);74(3):294–306. europeanurology.com
  5. MRI of Perianal Fistulas: Anatomy, Diagnosis, and Perianal Crohn Disease Treatment Monitoring. RadioGraphics (2025). rg.250033

MRI Patient Positioning — Quick Reference

Positioning, coil selection, centring landmarks, breathing strategy and comfort/immobilisation for common MRI exams, grouped by region. Expand a region to see the exam cards. Local protocols and coil availability vary — always follow your department’s SOP and manufacturer guidance.

Neuro7 exams

Brain (routine)

Position
Supine, head-first, arms by sides.
Coil
Head / head-neck array.
Landmark / centring
Centre on nasion (glabella); align canthomeatal line.
Breathing
n/a (still).
Immobilisation / comfort
Head cushions, forehead strap, ear plugs + defenders.
Tips / common errors
Keep head straight — rotation skews symmetric structures; pad to reduce motion.

Brain — epilepsy / hippocampal

Position
Supine, head-first, arms by sides.
Coil
Head / head-neck array.
Landmark / centring
Centre on nasion; angle obliques perpendicular to long axis of hippocampus.
Breathing
n/a.
Immobilisation / comfort
Head cushions, strap, hearing protection.
Tips / common errors
Prescribe thin coronal obliques ⟂ hippocampus; minimise head tilt for symmetry.

IAMs / CP angle

Position
Supine, head-first, arms by sides.
Coil
Head / head-neck array.
Landmark / centring
Centre on nasion; thin axial + high-res T2 through IACs.
Breathing
n/a.
Immobilisation / comfort
Head cushions, strap, ear protection.
Tips / common errors
Small FOV thin slices through IACs; symmetry critical for VII/VIII.

Pituitary / sella

Position
Supine, head-first, arms by sides.
Coil
Head array.
Landmark / centring
Centre on nasion; small-FOV coronal + sagittal through sella.
Breathing
n/a; dynamic post-contrast timing if microadenoma.
Immobilisation / comfort
Head cushions, strap, ear protection.
Tips / common errors
Thin (2–3 mm) coronal dynamic; time contrast for microadenoma.

Orbits

Position
Supine, head-first, eyes closed, gaze fixed straight ahead.
Coil
Head array (small surface coil optional).
Landmark / centring
Centre on orbits; fat-sat T2/T1 small FOV.
Breathing
n/a — instruct patient to keep eyes still.
Immobilisation / comfort
Head cushions, strap, ear protection.
Tips / common errors
Eyes still reduces motion blur; use fat suppression for orbital fat.

MRA — Circle of Willis

Position
Supine, head-first, arms by sides.
Coil
Head / head-neck array.
Landmark / centring
Centre on nasion; 3D TOF slab over circle of Willis.
Breathing
n/a.
Immobilisation / comfort
Head cushions, strap, ear protection.
Tips / common errors
Position slab low enough to capture terminal ICA/vertebrobasilar; no contrast for TOF.

Carotid MRA (neck)

Position
Supine, head-first, chin slightly extended, arms by sides.
Coil
Head-neck / neck array.
Landmark / centring
Centre on thyroid cartilage; coronal CE-MRA aortic arch → circle of Willis.
Breathing
Suspend breathing briefly for arch acquisition.
Immobilisation / comfort
Neck support, strap, ear protection.
Tips / common errors
Time the contrast bolus for arterial phase; cover arch to intracranial ICA.
Spine4 exams

Cervical spine

Position
Supine, head-first, arms by sides, shoulders down.
Coil
Head-neck + spine array.
Landmark / centring
Centre on thyroid cartilage (~C4).
Breathing
n/a; quiet breathing.
Immobilisation / comfort
Neck cushion, knee bolster, strap, ear protection.
Tips / common errors
Pull shoulders down to reduce brachial-plexus wrap; saturate swallowing motion.

Thoracic spine

Position
Supine, head-first, arms by sides.
Coil
Spine array (± body array).
Landmark / centring
Centre at mid-sternum (~T6); count from C7 or L5 to level.
Breathing
Quiet breathing.
Immobilisation / comfort
Knee bolster, strap, ear protection.
Tips / common errors
Use a vitamin-E/skin marker or count vertebrae to confirm level.

Lumbar spine

Position
Supine, head-first, knees flexed over bolster.
Coil
Spine array.
Landmark / centring
Centre on iliac crest (~L4).
Breathing
Quiet breathing.
Immobilisation / comfort
Large knee bolster (flattens lordosis), strap, ear protection.
Tips / common errors
Knee bolster reduces lordosis & back pain; sagittal to count levels.

Whole spine

Position
Supine, head-first, arms by sides.
Coil
Head-neck + full spine array (multi-station).
Landmark / centring
Centre first station at orbit; step-table sagittal C-to-sacrum.
Breathing
Quiet breathing.
Immobilisation / comfort
Neck + knee support, strap, ear protection.
Tips / common errors
Composed multi-station sagittal; keep spine straight for stitching.
MSK10 exams

Shoulder

Position
Supine, head-first, affected arm at side, hand supinated (palm up), slight external rotation.
Coil
Dedicated shoulder / flexible surface coil.
Landmark / centring
Centre on humeral head / coracoid; small FOV.
Breathing
n/a.
Immobilisation / comfort
Sandbag/strap on hand to hold external rotation, ear protection.
Tips / common errors
External rotation opens the joint; feet-first if narrow shoulders/claustrophobia.

Elbow

Position
Prone, arm extended overhead “superman” (or supine at side), thumb up.
Coil
Extremity / flexible surface coil.
Landmark / centring
Centre on olecranon / joint line.
Breathing
n/a.
Immobilisation / comfort
Foam pads around elbow, strap, ear protection.
Tips / common errors
Superman position centres elbow in bore; at-side alternative for large/older patients.

Wrist

Position
Prone, arm overhead “superman”, wrist pronated, or at side.
Coil
Wrist / small extremity coil.
Landmark / centring
Centre on radiocarpal joint.
Breathing
n/a.
Immobilisation / comfort
Foam pads, strap, ear protection.
Tips / common errors
Keep wrist in coil isocentre; superman reduces off-centre artefact.

Hand / fingers

Position
Prone, arm overhead “superman”, palm down on coil.
Coil
Small flexible / extremity coil.
Landmark / centring
Centre on metacarpals / affected digit.
Breathing
n/a.
Immobilisation / comfort
Pads to immobilise fingers, strap, ear protection.
Tips / common errors
Immobilise digit; place ROI at isocentre for small FOV/high resolution.

Hip (single)

Position
Supine, feet-first, legs straight, feet gently internally rotated & taped.
Coil
Body / flexible array over hip.
Landmark / centring
Centre on femoral head (~2 cm below ASIS line).
Breathing
Quiet breathing.
Immobilisation / comfort
Foot tape for internal rotation, knee support, ear protection.
Tips / common errors
Internal rotation of foot elongates femoral neck; contralateral hip for AVN compare.

Pelvis / SIJ

Position
Supine, feet-first, legs straight.
Coil
Body + spine array.
Landmark / centring
Centre midway between ASIS and pubic symphysis; oblique coronals along sacrum for SIJ.
Breathing
Quiet breathing.
Immobilisation / comfort
Knee support, strap, ear protection.
Tips / common errors
For SIJ prescribe semi-coronal oblique parallel to sacrum; fat-sat for oedema.

Knee

Position
Supine, feet-first, knee slightly flexed (~10–15°) & externally rotated ~15°.
Coil
Dedicated knee (HD) coil.
Landmark / centring
Centre on inferior pole of patella / joint line.
Breathing
n/a.
Immobilisation / comfort
Knee coil, foam wedge, strap, ear protection.
Tips / common errors
Slight external rotation aligns ACL for sagittal obliques; feet-first eases claustrophobia.

Ankle

Position
Supine, feet-first, ankle in neutral 90° dorsiflexion.
Coil
Ankle / foot (extremity) coil.
Landmark / centring
Centre on medial malleolus / tibiotalar joint.
Breathing
n/a.
Immobilisation / comfort
Coil + pads to hold 90°, strap, ear protection.
Tips / common errors
Neutral 90° avoids magic-angle on tendons; feet-first minimises bore travel.

Foot

Position
Supine, feet-first, foot in coil, toes up (or plantar per pathology).
Coil
Foot / extremity coil.
Landmark / centring
Centre on midfoot / affected region.
Breathing
n/a.
Immobilisation / comfort
Pads to immobilise, strap, ear protection.
Tips / common errors
Angle short-axis to metatarsals for forefoot; small FOV high resolution.

TMJ

Position
Supine, head-first, bite blocks for open/closed mouth series.
Coil
Bilateral small surface (TMJ) coils or head coil.
Landmark / centring
Centre on condyles; thin oblique sagittal ⟂ condylar axis.
Breathing
n/a.
Immobilisation / comfort
TMJ coils, bite block, head strap, ear protection.
Tips / common errors
Acquire closed then open (bite block) to assess disc position/reduction.
Body9 exams

Liver / MRCP

Position
Supine, head-first (or feet-first), arms above head.
Coil
Body array + spine array.
Landmark / centring
Centre on xiphisternum.
Breathing
Breath-hold in expiration; MRCP thick-slab often respiratory-triggered.
Immobilisation / comfort
Arms up on pads, strap, ear protection; belt for navigator.
Tips / common errors
Consistent expiration breath-holds; fast on secretin/fatty-meal per protocol.

Pancreas

Position
Supine, head-first, arms above head.
Coil
Body + spine array.
Landmark / centring
Centre on xiphisternum / L1 level.
Breathing
Breath-hold expiration; dynamic post-contrast phases.
Immobilisation / comfort
Arms up, strap, ear protection.
Tips / common errors
Thin axial dynamic for lesion conspicuity; consistent breath-hold timing.

Adrenals

Position
Supine, head-first, arms above head.
Coil
Body + spine array.
Landmark / centring
Centre on xiphisternum / upper abdomen.
Breathing
Breath-hold expiration.
Immobilisation / comfort
Arms up, strap, ear protection.
Tips / common errors
In/opposed-phase chemical shift for adenoma signal drop.

Kidneys / MR urography

Position
Supine, head-first, arms above head.
Coil
Body + spine array.
Landmark / centring
Centre midway xiphisternum–umbilicus.
Breathing
Breath-hold; heavily-T2 urography may be respiratory-triggered.
Immobilisation / comfort
Arms up, strap, ear protection; hydration ± furosemide per protocol.
Tips / common errors
Coronal thick-slab T2 urography; dynamic excretory phase for collecting system.

Small bowel — MR enterography

Position
Supine or prone, head-first, arms above head; oral contrast pre-filled.
Coil
Body + spine array.
Landmark / centring
Centre on umbilicus.
Breathing
Breath-hold + free-breathing cine of loops; antiperistaltic agent given.
Immobilisation / comfort
Arms up, strap, ear protection.
Tips / common errors
Ensure adequate luminal distension (oral prep); prone can spread loops.

Rectum

Position
Supine, head-first, arms across chest or up; empty rectum ± gel.
Coil
Body / pelvic array (small FOV).
Landmark / centring
Centre on symphysis pubis; obliques ⟂ tumour axis.
Breathing
Quiet breathing; antiperistaltic agent.
Immobilisation / comfort
Knee support, strap, ear protection.
Tips / common errors
High-res T2 obliques ⟂ tumour long axis; no fat-sat for staging.

Prostate

Position
Supine, head-first, arms across chest.
Coil
Pelvic phased-array (endorectal rarely).
Landmark / centring
Centre on symphysis pubis.
Breathing
Quiet breathing; antiperistaltic agent to reduce rectal motion.
Immobilisation / comfort
Knee support, strap, ear protection.
Tips / common errors
Antispasmodic + empty rectum reduce motion/susceptibility on DWI.

Female pelvis

Position
Supine, head-first, arms across chest.
Coil
Pelvic phased-array (body + spine).
Landmark / centring
Centre on symphysis pubis; obliques along uterine/cervical axis.
Breathing
Quiet breathing; antiperistaltic agent.
Immobilisation / comfort
Knee support, strap, ear protection.
Tips / common errors
Align obliques to uterine axis (endometrium) or cervical canal per indication.

Breast

Position
Prone, head-first, both breasts pendant in coil apertures, arms up.
Coil
Dedicated breast coil (bilateral).
Landmark / centring
Centre on nipple line / mid-breast.
Breathing
Free-breathing; dynamic contrast subtraction.
Immobilisation / comfort
Prone breast coil, pads, strap, ear protection.
Tips / common errors
Ensure breasts fully pendant with no skin folds; symmetric positioning for subtraction.
Cardiac / vascular3 exams

Cardiac — function / viability

Position
Supine, head-first, arms above head; ECG leads placed.
Coil
Cardiac phased-array + ECG gating.
Landmark / centring
Centre on mid-sternum / left chest.
Breathing
Repeated breath-holds in expiration; ECG-gated cine.
Immobilisation / comfort
ECG electrodes, arms up, strap, ear protection.
Tips / common errors
Good ECG trace essential; consistent end-expiration breath-holds for slice registration.

Aorta MRA

Position
Supine, head-first, arms above head; ECG for root.
Coil
Body + spine array (± ECG).
Landmark / centring
Centre over region (arch/thoracic/abdominal).
Breathing
Breath-hold for thoracic; timed CE-MRA bolus.
Immobilisation / comfort
Arms up, strap, ear protection.
Tips / common errors
Time contrast to arterial phase; ECG-gate root for aortic-valve/dissection flap.

Peripheral run-off MRA

Position
Supine, feet-first, legs straight & together, feet padded.
Coil
Peripheral vascular array + body/spine (multi-station).
Landmark / centring
Centre first station at renal arteries; bolus-chase to feet.
Breathing
Suspend breathing for abdominal station.
Immobilisation / comfort
Legs strapped together, foot pads, ear protection.
Tips / common errors
Bolus-chase timing critical to avoid venous contamination distally.
Head & neck / other3 exams

Neck (soft tissue)

Position
Supine, head-first, arms by sides, shoulders down, neutral neck.
Coil
Head-neck / neck array.
Landmark / centring
Centre on thyroid cartilage / hyoid.
Breathing
Quiet breathing; suspend swallowing during acquisition.
Immobilisation / comfort
Neck support, strap, ear protection.
Tips / common errors
Ask patient not to swallow during scans; saturate to reduce swallowing motion.

Brachial plexus

Position
Supine, head-first, arms by sides, shoulders relaxed and down.
Coil
Head-neck + spine array.
Landmark / centring
Centre on lower neck (~C7/T1).
Breathing
Quiet breathing.
Immobilisation / comfort
Neck & shoulder support, strap, ear protection.
Tips / common errors
Coronal/oblique STIR along plexus; drop shoulders to include roots to cords.

Fetal MRI

Position
Supine (or left-lateral decubitus if supine hypotension), feet-first, arms up or by sides.
Coil
Body + spine array over gravid uterus.
Landmark / centring
Centre over uterus per gestation (fundal height).
Breathing
Free-breathing SSFSE single-shot (motion-robust); no breath-hold.
Immobilisation / comfort
Wedge under right hip if needed, strap, ear protection; reassure re: safety.
Tips / common errors
Use fast single-shot to freeze fetal motion; left-tilt avoids aortocaval compression.

Feet-first entry (knee, ankle, foot, lower-limb vascular, pelvis, hip) reduces bore travel and helps claustrophobic patients. Breath-holds are performed in expiration for consistent diaphragm position. Hearing protection is mandatory for every patient.

Phase-encode direction & saturation bands


Two levers that decide where artefacts land — not whether they exist. Ghosting from motion, pulsation and aliasing (wrap) is always mapped along the phase-encode (PE) axis; you rotate that axis, and drop saturation bands, to push those ghosts off the anatomy you care about. Conventions below are widely taught but vendor- and site-dependent — reason from the artefact source, don’t memorise blindly.

The three reasons you swap PE direction
  • Move motion/pulsation ghosts off the ROI. Ghosts propagate along PE. Put PE perpendicular to the line joining the pulsatile/moving source and the target (e.g. swap so vessel ghosts run head–foot along the spine, not across the cord).
  • Shorten the scan. Scan time = TR × phase steps × averages. Put the shorter anatomical dimension in phase and cut phase FOV (rectangular FOV) → fewer phase steps → faster. Frequency direction is “free.”
  • Avoid wrap (aliasing). Orient PE along the dimension that fits the FOV, or add phase oversampling / a sat band over the wrapping tissue.

Neuro

Exam / sequencePE directionWhyExample / swap
Axial brain T2 / FLAIR / T1R ↔ LL–R is the shorter dimension → rectangular FOV shortens scan; throws CSF & vascular pulsation ghosts side-to-side, away from brainstem & midline.Swap to A–P if L–R wrap from broad shoulders/positioning.
Sagittal brainS ↔ I (head–foot)Keeps A–P vascular/CSF pulsation ghosts out of the sagittal display; foot–head fits the long axis.A–P acceptable with flow comp.
Orbits (axial/coronal)R ↔ LEye-motion ghosting travels with globe movement (up–down); PE R–L keeps that ghost off the globe & optic nerve.Add flow comp + thin slices; ask patient to fixate gaze.
IAM / posterior fossa (axial)R ↔ LDisplaces transverse sinus & basilar pulsation ghosts laterally, off the IACs / CP angle.Flow comp on T2.
MRA / TOFR ↔ L (axial slab)Minimises pulsation ghost across the circle of Willis; combine with flow comp and a superior/inferior travelling sat for arterial vs venous selectivity.Venous TOF → sat inferiorly; arterial → sat superiorly.

Axial-brain PE choice varies by vendor default (some ship A–P). The reasoning — shorter dimension + pulsation displacement — is what to teach.

Spine

Exam / sequencePE directionWhySat band
Sagittal C-spineS ↔ I (head–foot)Swallowing, pharyngeal motion and carotid pulsation are anterior; if PE were A–P their ghosts would project straight onto the cord. PE S–I runs those ghosts vertically instead.Anterior sat over pharynx / great vessels.
Sagittal T- / L-spineS ↔ I (head–foot)Aortic/IVC pulsation and bowel/respiratory motion are anterior — same logic, keep their ghosts off the canal & cord/conus.Anterior sat over aorta / bowel.
Axial C-spineA ↔ PShorter neck dimension; combine with anterior sat to knock down swallowing ghost.Anterior sat.
Axial L-spineA ↔ PFits the FOV; anterior sat suppresses aortic pulsation projecting posteriorly onto discs/canal.Anterior sat over aorta.

Body & pelvis

Exam / sequencePE directionWhySat / technique
Axial abdomen (liver, T2/T1)A ↔ PA–P is shorter → rectangular FOV; but respiratory ghost also runs A–P onto kidneys/liver — so pair with breath-hold or navigator, not just PE choice.Breath-hold / respiratory triggering; anterior sat over subcut fat.
Axial abdomen with arm-down wrapswap to R ↔ L or oversampleArms in the FOV wrap along phase; oversample or move PE to the non-wrapping axis.Phase oversampling / lateral sat.
Coronal abdomen/pelvisR ↔ LShorter dimension coronally; keeps aortic pulsation ghost lateral.Superior/inferior sat to cut in-flow artefact.
Prostate / rectum (axial T2)R ↔ LDisplaces rectal-gas susceptibility & iliac vessel pulsation laterally, off the peripheral zone.Anti-peristaltic (hyoscine/glucagon).
MRCP (coronal HASTE/3D)R ↔ LKeeps A–P respiratory/duodenal motion ghosts off the biliary tree.Respiratory triggering + oral negative contrast.

Cardiac & vascular

Exam / sequencePE directionWhySat / technique
Cardiac cine / black-bloodA ↔ P (with fold suppression)Chest wall & cardiac motion; PE choice + ECG gating keep ghosts off the myocardium.Inferior/anterior sat to null in-flowing blood (black-blood double IR); ECG gating.
Contrast MRAalong shortest FOV dimensionMinimise phase steps for speed within the arterial bolus window.No sat (want vessel signal); centric k-space ordering.

MSK

Exam / sequencePE directionWhySwap / sat
Axial kneeR ↔ LPopliteal artery is posterior & midline; PE R–L runs its pulsation ghost side-to-side, off the patellofemoral joint & menisci.Add sat over popliteal vessels if ghost persists.
Sagittal / coronal kneeS ↔ IKeeps popliteal pulsation ghost running head–foot, not across cruciates/menisci.Flow comp on PD/T2.
Axial shoulderA ↔ PAxillary vessel pulsation runs off the glenoid/labrum; A–P fits the FOV.Swap or sat if brachial pulsation crosses labrum.
Ankle / footS ↔ I or A ↔ PPosterior tibial vessel pulsation; orient PE to keep ghost off the tibiotalar joint/tendons.Anterior/posterior sat as needed.
Long-axis limbs / run-offalong limb axisFewer phase steps over the long, narrow FOV; keeps vessel ghosts running with the limb.Travelling sat for run-off.

Saturation bands — types & placement

  • Spatial pre-sat A slab that tips & spoils signal from tissue before readout. Place it perpendicular to the flow/motion and between the source and the ROI — never overlapping the ROI. Uses: anterior sat (spine — swallowing, aortic/carotid pulsation, respiration); superior/inferior sat (null in-flowing arterial or venous blood; black-blood cardiac; venous vs arterial MRA selectivity); lateral sat (arm/fold suppression).
  • Travelling / tracking sat Moves with the slice through the volume — keeps flow suppression consistent across a stack (run-off MRA, TOF).
  • Chemical (fat) sat Frequency-selective, not spatial — nulls fat everywhere in the FOV (SPAIR/fat-sat). Distinct from spatial sat; combine both when needed.
  • Cost: each spatial sat pulse adds RF (SAR) and can reduce slices per TR; use the minimum that clears the artefact.

Reference values represent typical practice; always tailor to scanner, coil and patient. Educational content, not a substitute for your department’s validated protocols.

PACS: definitions, what to send & reformats


Getting the right images to the right place is part of the exam, not an afterthought. Below: what the archive tiers actually mean, the minimum series a radiologist expects for each body part, and the reformats (MPRs/MIPs) the radiographer is expected to reconstruct and push — before the patient leaves.

Core PACS terminology

PACS
Picture Archiving & Communication System — stores, retrieves, distributes and displays medical images. Talks to modalities and the RIS/EHR via DICOM and HL7.
Primary archive
The authoritative, long-term store of record — the “source of truth” the site is medico-legally required to retain for the full retention period. High-integrity, backed up, usually on-site or primary cloud.
Secondary archive
A second independent copy for redundancy / disaster recovery / business continuity — geographically or logically separate from primary, so loss of one site doesn’t lose the study. May be lower-cost/slower (“nearline”) storage.
VNA
Vendor-Neutral Archive — a storage layer independent of any single PACS vendor, holding images in standard DICOM so multiple PACS/EHR viewers can access one shared copy. Often serves as the primary archive across departments.
On / near / off-line
Tiered storage by access speed: on-line = instant (recent studies, fast disk); near-line = seconds–minutes (older studies, slower/cheaper media); off-line = manual retrieval (archive/tape).
DICOM node / AE title
A network destination on the DICOM network. Each device has an Application Entity (AE) title, IP and port — you “send to” a node by its AE title.
C-STORE / query-retrieve
DICOM services: C-STORE pushes images to a node; C-FIND / C-MOVE (query-retrieve) pulls studies from an archive.
Worklist (MWL)
Modality Worklist — the scanner pulls booked patient/exam demographics from the RIS so IDs and accession numbers match automatically (avoids typos & mismatched studies).
Accession number
Unique per-exam identifier from the RIS that ties images ↔ order ↔ report. Wrong accession = study lands on the wrong order.
Series vs study
A study is the whole exam for one accession; a series is one acquisition/sequence within it.
Presentation state (GSPS)
Saved annotations, measurements, window/level and reformat orientation stored alongside images so the reader sees what you set up.
Key images / KOS
Key Object Selection — flagged representative images (e.g. the measured lesion) so the reader/clinician finds the finding fast.
Thin vs thick
Thin-slice source data feeds reformats & 3D; thick/averaged series are for quick reading. Archive both when the protocol needs post-processing later.
Send discipline (every exam): verify patient ID & accession from the worklist before pushing · send all acquired series plus required reformats · confirm the study “verified/complete” on PACS before the patient leaves · check both primary and secondary archive received it if your site doesn’t auto-mirror · save presentation state/key images for measured findings.

What to send & which reformats to build — by body part

Body partSeries to sendReformats / reconstructions to make & send
Brain (routine)All acquired: T1, T2, FLAIR, DWI + ADC map, T2* / SWI, post-Gd T1 (if given).SWI minIP (thick) for microbleeds/veins; 3D T1 post-Gd → ax/cor/sag MPR; ensure ADC map is generated & sent (not just DWI).
Brain — epilepsy/tumour (3D)3D FLAIR, 3D T1 (pre/post), DWI+ADC.Thin-slice 3D → orthogonal MPRs; hippocampal oblique-coronal reformats perpendicular to long axis of hippocampus.
MRA — intracranial / carotid TOFSource axial images + acquired.MIP: full-volume + targeted/rotational MIPs (per-vessel), plus keep source images (MIP can hide small aneurysms).
Pituitary / IAMThin coronal & sagittal T1/T2 ± dynamic post-Gd.Small-FOV MPRs if 3D acquired; send dynamic phases in order.
Cervical / lumbar spineSag T1, Sag T2 (± STIR), Axial T2 (± T1) through relevant levels.Axial obliques angled to each disc space for stenosis; if 3D, cor/sag reformats. Confirm level labelling.
MRCPThin-slab 3D + thick-slab radial HASTE, axial/coronal T2.Rotational MIP / radial reprojections of the biliary tree from the 3D volume; send the radial set.
Liver / abdomen (dynamic)In/out-phase, T2, DWI+ADC, dynamic post-Gd (pre, arterial, portal, delayed / hepatobiliary).Subtraction (post − pre) for enhancement; label dynamic phases; ADC map; coronal reformat if 3D.
Prostate (mpMRI)T2 (ax/cor/sag), DWI high-b + ADC, DCE dynamic.Calculated high-b (e.g. b1400) if not acquired; ADC map; ensure DCE series ordered/labelled; PI-RADS key images.
Pelvis — gynae / rectalT2 (ax/sag/cor), oblique T2 to organ axis, DWI+ADC, ± post-Gd.Oblique reformats/acquisitions perpendicular & parallel to organ axis (short-axis to cervix/rectal wall); ADC map.
Cardiac MRCines (SA stack, 2/3/4-ch), T1/T2 mapping, LGE, perfusion.Reformat short-axis stack from long-axis planning; map images (native/post-contrast T1, ECV if computed); send mapping colour overlays + source.
MSK — knee/shoulder/ankleAll planes PD/T2 fat-sat + T1; cartilage/effusion sequences.If 3D isotropic → orthogonal & oblique MPRs (along ligament/labrum); radial reformats for hip labrum/shoulder.
MSK — 3D isotropic / tumourIsotropic source + standard planes.Orthogonal MPRs; long-axis + short-axis to the lesion/bone; whole-lesion measurement key images.
Peripheral / contrast MRA run-offSource stations, mask & post-contrast.Subtracted MIPs per station + composed whole-leg MIP; keep source for stenosis grading.
Reformat rule of thumb: always archive the thin-slice source whenever you send a MIP/minIP/MPR — projections can obscure small lesions, and the reader (or a later re-read) may need to re-reconstruct. Label every reformat clearly (plane + technique) so it is unambiguous in the study.

Retention periods, archive architecture (VNA/primary/secondary) and required reformats vary by jurisdiction and department — follow your local imaging IT and reporting-radiologist standards. Educational content only.